Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 46,179 | 0 | 49,181 | 23,137 | 0 |
| Operating Income | -46,179 | N/A | -49,181 | -23,137 | N/A |
| Other Income | 4,073 | 0 | 4,424 | 1,082 | 0 |
| Pre-tax Income | -42,106 | 0 | -44,757 | -22,055 | 0 |
| Net Income Continuous | -42,106 | N/A | -44,757 | -22,055 | N/A |
| Net Income | $-42,106 | $N/A | $-44,757 | $-22,055 | $N/A |
| EPS Basic Total Ops | -526.11 | N/A | -1.03 | -54.23 | N/A |
| EPS Basic Continuous Ops | -0.53 | N/A | -1.03 | -0.05 | N/A |
| EPS Diluted Total Ops | -526.11 | N/A | -1.03 | -54.23 | N/A |
| EPS Diluted Continuous Ops | -0.53 | N/A | -1.03 | -0.05 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.53 | -0.49 | -1.03 | N/A | N/A |
| EBITDA(a) | $-45,993 | $N/A | $-49,181 | $-23,083 | $N/A |